These transmembrane proteins are activated following binding with peptide growth factors of the egffamily of proteins. Four members of the erbb family have been identified. Epidermal growth factor egf is a protein that stimulates cell growth and differentiation by binding to its receptor, egfr. Epidermal growth factor egf receptors also known as erbb function in development, proliferation and cell survival.
Aberrant epidermal growth factor receptor signaling and. The epidermal growth factor receptor egfr belongs to the erbb family of receptor tyrosine kinases rtk. Epidermal growth factor receptor signaling network in pancreatic cancer. Assessment and prognostic significance of epidermal growth factor receptor viii mutation in glioblasotma patients treated with concurrent and adjuvant temozolomide radiochemotherapy. Growth factor receptor signaling inhibition prevents sars. The egfr was the first receptor to be proposed as a target for cancer therapy, and after 2. Several epidermal growth factor receptor egfr tyrosine kinase inhibitors have been developed and approved by food and drug administration for the treatment of nonsmallcell lung cancers, but their efficacy can be compromised by acquired drug resistance conferred by egfr mutant variants. Epidermal growthfactor receptor egfr inhibitors have become a mainstay of treatment of metastatic colorectal cancer mcrc in patients with wildtype ras. Epidermal growth factor receptor egfr signaling in cancer. Amplification of epidermal growth factor receptor egfr and its active mutant egfrviii occurs frequently in glioblastoma gbm. Epidermal growth factor receptormediated stat3 signaling. Epidermal growth factor receptor egfrdependent signaling is involved in many physiological.
Epidermal growth factor receptor egfr is expressed in 50% of nsclcs, and its. Epidermal growth factor receptor cell proliferation signaling. Wildtype egfr is classically activated through ligand binding by factors such as epidermal growth factor egf, transforming growth factor alpha, heparinbinding egflike growth. Epidermal growth factor receptor mutations in lung cancer. Egfr epidermal growth factor receptor tocris bioscience. The epidermal growth factor receptor egfr is a membrane protein that regulates cell proliferation, differentiation and survival, and is a drug target for cancer therapy. The epidermal growth factor receptor egfr is a receptor tyrosine kinase receptor that is frequently expressed in epithelial tumors. The phosphorylation of protein kinases leads to the activation of signaltransduction pathways, which have. Pdf targeting the egfr signaling pathway in cancer therapy.
Proliferation of mcf7egfr and parental cells was induced by 17. Identification of a mutation in the extracellular domain of the epidermal growth factor receptor conferring cetuximab resistance in. Egf receptor signaling has an important role for glycolysis, pentose phosphate pathway, and pyrimidine biosynthesis in egfrmutated lung cancer. Epidermal growth factor receptor family activation and. Epidermal growth factor receptor egfr mutations enable constitutive active downstream signaling of pi3kakt, kraserk and jakstat pathways, and promote tumor progression by inducing uncontrolled proliferation, evasion of apoptosis and migration of nonsmall cell lung cancer nsclc. Egfr signaling pathways that promote the growth and spread of cancer cells. The egfr was the first receptor to be proposed as a target for cancer therapy, and after 2 decades of intensive research, there are several antiegfr agents available in the clinic. Gastric cancers frequently overexpress the epidermal growth factor receptor egfr, which has been implicated in pathological processes including tumor cell motility, invasion and. Epidermal growth factor receptor signalling in human breast cancer.
Egfr, a transmembrane glycoprotein is a member of the erbb receptor tyrosine kinase superfamily. Transactivation of epidermal growth factor receptor. Epidermal growth factor receptors egfrs are a large family of receptor tyrosine kinases tk expressed in several types of cancer, including. Epidermal growth factor receptor targeting and challenges. Epidermal growth factor receptor egfr phosphorylation. Molecular targeting strategies for cancer therapy are distinct from conventional. Epidermal growth factor receptor inhibition strategies in oncology in. The egfr was the first receptor to be proposed as a target. A year has passed since mutations of the tyrosine kinase domain of the epidermal growth factor receptor egfr were discovered in patients with nonsmall cell lung cancer nsclc who had. Decades of research in molecular oncology have brought about promising new therapies which are designed to target specific molecules which promote tumor growth and survival. The role of epidermal growth factor receptor in cancer. Epidermal growth factor receptor egfr is occasionally amplified andor mutated in nonsmall cell lung cancer nsclc and can be coexpressed with other members of the.
Epidermal growth factor receptor egfr is a key factor in epithelial malignancies, and its activity enhances tumor growth, invasion, and metastasis. Structural basis for inhibition of the epidermal growth. Epidermal growth factor receptor egfr is an established therapeutic target in various solid malignancies including squamous cell carcinoma of the head and neck scchn and colon. Objectives upregulation of epidermal growth factor receptor egfr is critical for the loss of growth control in a variety of human cancers including squamous cell cancers of the head and neck scchn. The epidermal growth factor receptor egfr is a receptor tyrosine. The egfr gene provides instructions for making a receptor protein called the epidermal growth factor receptor, which spans the cell membrane so that one end of the protein remains inside. Targeting the egfr signaling pathway in cancer therapy ncbi.
Mutations in the tyrosine kinase epidermal growth factor receptor egfr induce oncogenic addiction in lung adenocarcinoma lad. These transmembrane proteins are activated following binding with peptide. It functions in a wide range of cellular processes. Epidermal growth factor receptor egfr tyrosine kinase inhibitors gefitinib and erlotinib are effective therapies for nonsmall cell lung cancer patients whose tumors harbor somatic. The epidermal growth factor receptor egfr is a long known, versatile signal transducer that has been well conserved during evolution. Egfr binds to its cognate ligand egf, which further.
Recent structural studies of epidermal growth factor receptor egfr family extracellular regions have identified an unexpected mechanism for ligandinduced receptor dimerization that has important. Sigismund, in progress in molecular biology and translational science, 2016. Epidermal growth factor receptor as a target in pancreatic. In addition, such egfr mutations increase the susceptibility of patients with nsclc to tyrosine kinase. Epidermal growth factor receptor egfr and ybox binding protein 1 yb1 are detected in basallike breast cancer specimens on a tumour tissue microarray. Growth factor receptor gfr signaling plays important roles in cancer pathogenesis and has also been reported to be crucial for infection with some viruses beerli et al. The role of epidermal growth factor receptor in cancer metastasis. They activate a network of signaling pathways that is tightly regulated by. Request pdf epidermal growth factor receptor egfr signaling in cancer the epidermal growth factor receptor egfr belongs to the erbb family of receptor. Pdf epidermal growth factor receptor egfr signaling in.
Research paper assessment of epidermal growth factor. The epidermal growth factor receptor egfr belongs to a family of receptor tyrosine. The epidermal growth factor receptor egfr is a receptor tyrosine kinase that is commonly upregulated in cancers such as in nonsmallcell lung cancer, metastatic colorectal cancer, glioblastoma, head and. The receptor tyrosine kinase signal can be terminated by endocytosis of the phosphorylated receptorligand complex yarden 2001. Evaluation of epidermal growth factor receptor signaling. Epidermal growth factor receptor and notch signaling in. Advanced nonsmallcell lung cancer nsclc is the leading cause of cancerrelated deaths in the world.
Notch and epidermal growth factor receptor egfr signaling are essential in cell proliferation, differentiation, and apoptosis, and thereby may contribute to the development of lung cancer. The epidermal growth factor receptor egfr is a receptor tyrosine kinase of the erbb family. Novel therapeutic strategies targeting the epidermal growth factor. Evidence suggests that the egfr is involved in the pathogenesis and progression of different carcinoma types. Epidermal growth factor receptor egfr inhibitors are valuable therapeutics in metastatic colorectal cancer mcrc. Telomere length regulation through epidermal growth factor.
Epidermal growth factor receptor egfr signaling in. Therefore, identification of new crosstalk between such pathways may be effective to introduce new strategies for targeted therapy of cancer. Epidermal growth factor receptor egfr mutations in lung. Mechanisms of acquired resistance to epidermal growth.
Epidermal growth factor receptor cell proliferation. Gfr activation leads to the modulation of a wide range of cellular. Discovery of potent and selective epidermal growth factor. Nonsmallcell lung cancer nsclc, the most prevalent subtype of this recalcitrant cancer, is usually diagnosed at advanced stages, and available systemic therapies are mostly palliative. Epidermal growth factor egf receptor signaling and. Antiegfr monoclonal antibodies moabs, such as cetuximab or panitumumab, in.
Targeted therapeutics that disable signaling molecules upon which in vivo growth and survival advantages of malignant cells pivot, illustrated by gleevec inhibition of bcrabl, are. However, the linkage between oncogenic mutated egfr and cancer cell metabolism has not yet been clearly elucidated. Human egf is 6kda and has 53 amino acid residues and three intramolecular disulfide. These transmembrane proteins are activated following binding with peptide growth factors of. Met signaling overcomes epidermal growth factor receptor. Seven genetically distinct ligands egf, transforming growth factor. The epidermal growth factor receptor egfr, a member of the erbbher family of receptor proteins, initiates a complex and multilayered signaling cascade which influences many facets of tumor cell. Epidermal growth factor receptor egfr is the key molecular target for nonsmall cell lung cancer nsclc due to its major contribution to complex signaling cascades modulating the survival of. While egfr and egfrviii play critical roles in pathogenesis, targeted. Several epidermal growth factor receptor egfr tyrosine kinase inhibitors have been developed and approved by food and drug administration for the treatment of nonsmallcell lung cancers, but their. Role of epidermal growth factor receptor in breast cancer. Implementing antiepidermal growth factor receptor egfr.
580 291 1024 1054 1251 1029 1438 1296 1202 682 193 1155 898 83 752 1481 1414 876 1013 1170 1017 405 1291 1513 896 679 1510 546 1250 1281 524 381 276 169 1472 1316 509 1200 547 575 781 290 52 109 607 1387 1203 86